// App-Quantinova.ai

1366 : Evaluation of Synovial Fluid 14-3-3η Protein As a Marker of Joint Damage in Rheumatoid Arthritis Patients

Researchers

Presenter

  • Nevin Hammam

Principal Investigators

  • Shaimaa Salah

  • Anthony Marotta

  • Emad F. Kholef

Medical Centers

  • Rheumatology and Rhabilitation, Assiut University, Assiut, Egypt

  • University of Alberta, Edmonton, AB, Canada

  • Rheumatology, Rehabilitation and Physical Medicine department, Faculty of Medicine, Assiut, Assiut, Egypt

  • Augurex Life Science Corp, North Vancouver, Canada

  • Clinical Pathology Department, Assiut Uni- versity Hospitals, Assiut, Egypt

Locations

  • Egypt

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • 14-3-3eta

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved